About Neuravi
Neuravi is a company based in Galway (Ireland) founded in 2009 was acquired by DePuy Synthes in April 2017.. Neuravi has raised $27.59 million across 4 funding rounds from investors including European Union, Life Sciences Partners and Western Development Commission. Neuravi operates in a competitive market with competitors including Rapid Medical, Cardiovascular Systems, Contego Medical, AngioScore and Echopoint Medical, among others.
- Headquarter Galway, Ireland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neuravi Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27.59 M (USD)
in 4 rounds
-
Latest Funding Round
$484.04 K (USD), Grant
Nov 01, 2017
-
Investors
European Union
& 6 more
-
Employee Count
Employee Count
-
Acquired by
DePuy Synthes
(Apr 10, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neuravi
Neuravi has successfully raised a total of $27.59M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $484.04 thousand completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $484,043
-
First Round
First Round
(11 Jul 2012)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Grant - Neuravi | Valuation |
investors |
|
| Nov, 2016 | Amount | Debt – Venture - Neuravi | Valuation |
investors |
|
| Jun, 2015 | Amount | Series B - Neuravi | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Neuravi
Neuravi has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Life Sciences Partners and Western Development Commission. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative financing is provided by IPF Partners for healthcare.
|
Founded Year | Domain | Location | |
|
Private equity & debt fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Early stage venture capital is provided to Irish startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neuravi
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Neuravi
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neuravi Comparisons
Competitors of Neuravi
Neuravi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, Cardiovascular Systems, Contego Medical, AngioScore and Echopoint Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
Devices for treating peripheral and coronary vascular disease are developed.
|
|
| domain | founded_year | HQ Location |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| domain | founded_year | HQ Location |
Scoring balloon catheters for coronary and peripheral angioplasty are developed.
|
|
| domain | founded_year | HQ Location |
Smart devices for monitoring coronary artery disease are developed.
|
|
| domain | founded_year | HQ Location |
Embolization devices are developed using Shape Memory Polymer foams.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neuravi
Frequently Asked Questions about Neuravi
When was Neuravi founded?
Neuravi was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is Neuravi located?
Neuravi is headquartered in Galway, Ireland.
Is Neuravi a funded company?
Neuravi is a funded company, having raised a total of $27.59M across 4 funding rounds to date. The company's 1st funding round was a Series B of $21.21M, raised on Jul 11, 2012.
What does Neuravi do?
Neuravi was founded in 2009 in Galway, Ireland, within the medical device sector. A platform for treating acute ischemic stroke is being developed, featuring the EmboTrap revascularization device, which removes clots from the vascular system. The product has received CE marking in Europe but awaits approval for use in the United States. Operations are centered on advancing endovascular solutions for stroke care.
Who are the top competitors of Neuravi?
Neuravi's top competitors include Rapid Medical, Contego Medical and Limflow.
Who are Neuravi's investors?
Neuravi has 7 investors. Key investors include European Union, Life Sciences Partners, Western Development Commission, DePuy Synthes, and IPF Partners.